Clinical studies

Search documents
Quince Therapeutics, Inc. (QNCX) Analyst/Investor Day Transcript
Seeking Alphaยท 2025-10-02 21:12
PresentationDirk ThyeCEO, Chief Medical Officer & Director Greetings, everyone, and welcome to our first ever Investor Day for Quince Therapeutics. My name is Dirk Thye, and I'll be walking you through the beginning elements of our presentation. We've got a full agenda for you today. I'm going to start by giving you an overview of Quince Therapeutics, our technology, our development plans and our key investment highlights. And then I'm going to hand it over to a series of departmental and technical experts ...